Skip to main content

Bone mineral density and its contributing factors in Egyptian children with cystic fibrosis

Abstract

Background

Cystic fibrosis (CF) is an autosomal recessive disorder that, despite advances in medical care, continues to be a life-limiting disease. With increase in life expectancy of the CF population, bone disease has emerged as a common complication.

Aim

The aim of the study was to determine bone mineral density (BMD) and total body composition (TBC) in a sample of Egyptian children with CF and assess the contributing factors that might be related to BMD deficits.

Materials and methods

This was a cross-sectional case–control study that included 15 children with CF who were of a mean age of 6.3±3.68 years (2.5–15 years) and were diagnosed by sweat chloride testing. All CF children were subjected to detailed history taking, thorough clinical examination, laboratory investigations, and pulmonary function tests. They also underwent growth, puberty, and nutrition evaluation. BMD and TBC were evaluated using dual-energy X-ray absorptiometry.

Results

CF children had significantly decreased mean BMD and TBC compared with the control group. An overall 26.66% of these patients had osteopenia and one patient was 3 years old. They also showed delayed growth when compared with Egyptian standards, and most of them (> 80%) presented with recurrent chest infections, malabsorption, undernutrition, and treatment with inhaled steroids for more than 6 months.

Conclusion

We demonstrated the presence of osteopenia in our CF patients that presented early in life. Improving nutritional status, correcting malabsorption, and limiting chest infections are necessary for prevention. Annual assessment of BMD and body composition should be initiated early in life to target those who need preventive treatment against osteoporosis and reduce the risk for fractures later in life.

References

  1. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr 1993;122:1–9.

    Article  CAS  Google Scholar 

  2. Douros K, Loukou I, Nicolaidou P, Tzonou A, Doudounakis S. Bone mass density and associated factors in cystic fibrosis patients of young age. J Paediatr Child Health 2008;44:681–685.

    Article  Google Scholar 

  3. Gulack BC, Hirji SA, Hartwig MG. Bridge to lung transplantation and rescue post-transplant: the expanding role of extracorporeal membrane oxygenation. J Thorac Dis 2014;6:1070–1079.

    PubMed  PubMed Central  Google Scholar 

  4. Sugarman EA, Rohlfs EM, Silverman LM, Allitto BA. CFTR mutation distribution among U.S. Hispanic and African American individuals: evaluation in cystic fibrosis patient and carrier screening populations. Genet Med 2004;6:392–399.

    Article  Google Scholar 

  5. Lai HC, Kosorok MR, Sondel SA, Chen ST, FitzSimmons SC, Green CG et al. Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition. J Pediatr 1998;132:478–485.

    Article  CAS  Google Scholar 

  6. Naguib ML, Schrijver I, Gardner P, Pique LM, Doss SS, Abu Zekry MA et al. Cystic fibrosis detection in high-risk Egyptian children and CFTR mutation analysis. J Cyst Fibros 2007;6:111–116.

    Article  CAS  Google Scholar 

  7. Döring G, Hoiby NGroup CS. Early intervention and prevention of lung disease in cystic fibrosis: a European consensus. J Cyst Fibros 2004;3:67–91.

    Article  Google Scholar 

  8. Conway SP, Morton AM, Oldroyd B, Truscott JG, White H, Smith AH et al. Osteoporosis and osteopenia in adults and adolescents with cystic fibrosis: prevalence and associated factors. Thorax 2000;55:798–804.

    Article  CAS  Google Scholar 

  9. Aris RM, Merkel PA, Bachrach LK, Borowitz DS, Boyle MP, Elkin SL et al. Guide to bone health and disease in cystic fibrosis. J Clin Endocrinol Metab 2005;90:1888–1896.

    Article  CAS  Google Scholar 

  10. Sermet-Gaudelus I, Souberbielle JC, Ruiz JC, Vrielynck S, Heuillon B, Azhar I et al. Low bone mineral density in young children with cystic fibrosis. Am J Respir Crit Care Med 2007;175:951–957.

    Article  Google Scholar 

  11. Mishra A, Greavest R, Massie J. The relevance of sweat testing for the diagnosis of cystic fibrosis in the genomic era. Clin Biochem Rev 2005;26:135–153.

    PubMed  PubMed Central  Google Scholar 

  12. Buzzard IM, Price KS, Warren RA. Considerations for selecting nutrient-calculation software: evaluation of the nutrient database. Am J Clin Nutr 1991;54:7–9.

    Article  CAS  Google Scholar 

  13. Thomsen J, Evald P, Skieller V, Björk A. A comparative study of two different methods of measuring stature and the velocity of growth in children and adults. Eur J Orthod 1990;12:166–173.

    Article  CAS  Google Scholar 

  14. Shaw NJ. Osteoporosis in paediatrics. Arch Dis Child Educ Pract Ed 2007;92:169–175.

    Article  CAS  Google Scholar 

  15. Bianchi ML. Osteoporosis in children and adolescents. Bone 2007;41:486–495.

    Article  Google Scholar 

  16. Lu Y, Shu H, Zheng Y, Li C, Liu M, Chen Z et al. Comparison of fat-free mass index and fat mass index in Chinese adults. Eur J Clin Nutr 2012;66:1004–1007.

    Article  CAS  Google Scholar 

  17. Abdul Wahab A, Hammoudeh M, Allangawi M, Al-Khalaf F, Chandra P. Bone mineral density in cystic fibrosis patients with the CFTR I1234V mutation in a large kindred family is associated with pancreatic sufficiency. Int J Rheumatol 2014;2014:465395.

    Article  Google Scholar 

  18. El-Falaki MM, Shahin WA, El-Basha NR, Ali AA, Mehaney DA, El-Attar MM. Profile of cystic fibrosis in a single referral center in Egypt. J Adv Res 2014;5:563–568.

    Article  CAS  Google Scholar 

  19. Haworth CS, Selby PL, Webb AK, Martin L, Elborn JS, Sharples LD et al. Inflammatory related changes in bone mineral content in adults with cystic fibrosis. Thorax 2004;59:613–617.

    Article  CAS  Google Scholar 

  20. Conway SP, Oldroyd B, Brownlee KG, Wolfe SP, Truscott JG. A cross-sectional study of bone mineral density in children and adolescents attending a Cystic Fibrosis Centre. J Cyst Fibros 2008;7:469–476.

    Article  Google Scholar 

  21. Ross KR, Chmiel JF, Konstan MW. The role of inhaled corticosteroids in the management of cystic fibrosis. Paediatr Drugs 2009;11:101–113.

    Article  Google Scholar 

  22. Walkowiak J, Sands D, Nowakowska A, Piotrowski R, Zybert K, Herzig KH et al. Early decline of pancreatic function in cystic fibrosis patients with class 1 or 2 CFTR mutations. J Pediatr Gastroenterol Nutr 2005;40:199–201.

    Article  CAS  Google Scholar 

  23. Baker SS. Delayed release pancrelipase for the treatment of pancreatic exocrine insufficiency associated with cystic fibrosis. Ther Clin Risk Manag 2008;4:1079–1084.

    Article  CAS  Google Scholar 

  24. Weintraub A, Blau H, Mussaffi H, Picard E, Bentur L, Kerem E et al. Exocrine pancreatic function testing in patients with cystic fibrosis and pancreatic sufficiency: a correlation study. J Pediatr Gastroenterol Nutr 2009;48:306–310.

    Article  Google Scholar 

  25. Buntain HM, Greer RM, Schluter PJ, Wong JC, Batch JA, Potter JM et al. Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study. Thorax 2004;59:149–155.

    Article  CAS  Google Scholar 

  26. Ujhelyi R, Treszl A, Vásárhelyi B, Holics K, Tóth M, Arató A et al. Bone mineral density and bone acquisition in children and young adults with cystic fibrosis: a follow-up study. J Pediatr Gastroenterol Nutr 2004;38:401–406.

    Article  Google Scholar 

  27. Kelly T, Buxbaum J. Gastrointestinal manifestations of cystic fibrosis. Dig Dis Sci 2015;60:1903–1913.

    Article  Google Scholar 

  28. Sheikh S, Gemma S, Patel A. Factors associated with low bone mineral density in patients with cystic fibrosis. J Bone Miner Metab 2015;33:180–185.

    Article  CAS  Google Scholar 

  29. Buntain HM, Schluter PJ, Bell SC, Greer RM, Wong JC, Batch J et al. Controlled longitudinal study of bone mass accrual in children and adolescents with cystic fibrosis. Thorax 2006;61:146–154.

    Article  CAS  Google Scholar 

  30. Hardin DS, Arumugam R,Seilheimer DK, LeBlanc A, Ellis KJ. Normal bone mineral density in cystic fibrosis. Arch Dis Child 2001;84:363–368.

    Article  CAS  Google Scholar 

  31. Gronowitz E, Garemo M, Lindblad A, Mellström D, Strandvik B. Decreased bone mineral density in normal-growing patients with cystic fibrosis. Acta Paediatr 2003;92:688–693.

    Article  CAS  Google Scholar 

  32. Bianchi ML, Romano G, Saraifoger S, Costantini D, Limonta C, Colombo C. BMD and body composition in children and young patients affected by cystic fibrosis. J Bone Miner Res 2006;21:388–396.

    Article  Google Scholar 

  33. Javier RM, Jacquot J. Bone disease in cystic fibrosis: what’s new? Joint Bone Spine 2011;78:445–450.

    Article  Google Scholar 

  34. Ellis KJ. Body composition of a young, multiethnic, male population. Am J Clin Nutr 1997;66:1323–1331.

    Article  CAS  Google Scholar 

  35. Stettler N, Kawchak DA, Boyle LL, Propert KJ, Scanlin TF, Stallings VA et al. Prospective evaluation of growth, nutritional status, and body composition in children with cystic fibrosis. Am J Clin Nutr 2000;72:407–413.

    Article  CAS  Google Scholar 

  36. Salamoni F, Roulet M, Gudinchet F, Pilet M, Thiébaud D, Burckhardt P. Bone mineral content in cystic fibrosis patients: correlation with fat-free mass. Arch Dis Child 1996;74:314–318.

    Article  CAS  Google Scholar 

  37. Sood M, Hambleton G, Super M, Fraser WD, Adams JE, Mughal MZ. Bone status in cystic fibrosis. Arch Dis Child 2001;84:516–520.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hala M. Koura.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Naguib, M.L., Koura, H.M., Mahmoud, M.M. et al. Bone mineral density and its contributing factors in Egyptian children with cystic fibrosis. Egypt J Bronchol 10, 197–205 (2016). https://doi.org/10.4103/1687-8426.184372

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/1687-8426.184372

Keywords